HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Double-blind comparison of midazolam and temazepam as oral premedicants for outpatient anaesthesia.

Abstract
Oral premedication with midazolam 7.5 mg was compared with temazepam 20 mg in a double-blind study of sixty patients undergoing day-stay urological surgery. One hour following ingestion similar degrees of anxiolysis and sedation were reported by patients for both compounds. However, midazolam was observed by anaesthetists to produce the greater anxiolytic effect and was given the better overall assessment. Midazolam produced significantly greater amnesia both at the time of induction and 30 minutes postoperatively. At the time of discharge four hours postoperatively no significant difference could be observed in psychomotor performance or subjective sedation although on the evening of surgery the temazepam group had a greater incidence of sleepiness and an earlier time to retiring. Although the differences were small, the residual post-discharge effects of temazepam lead us to conclude that midazolam 7.5 mg is the more suitable premedicant for outpatient use.
AuthorsT G Short, D C Galletly
JournalAnaesthesia and intensive care (Anaesth Intensive Care) Vol. 17 Issue 2 Pg. 151-6 (May 1989) ISSN: 0310-057X [Print] United States
PMID2566287 (Publication Type: Clinical Trial, Comparative Study, Controlled Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Anxiety Agents
  • Temazepam
  • Midazolam
Topics
  • Adult
  • Ambulatory Surgical Procedures
  • Amnesia
  • Anti-Anxiety Agents (administration & dosage)
  • Anxiety (prevention & control)
  • Double-Blind Method
  • Female
  • Humans
  • Male
  • Midazolam (administration & dosage, therapeutic use)
  • Preanesthetic Medication
  • Psychomotor Performance (drug effects)
  • Temazepam (administration & dosage, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: